Global Hereditary Cancer Testing Market Valued at USD 147.62 Billion by 2024
Growing demand for non-invasive techniques for detection of hereditary cancer coupled with government funding for improvement of rapid diagnostics and rising concerns of hereditary cancer are the major driving factors of hereditary cancer testing market. Difficulties in accessing the complete genomic data for early detection and prevention will influence the market growth during the forecast period.
View full press release